Welcome to the Division of Nuclear Medicine. The Division provides the radionuclide studies for diagnosis and therapy. Our Division provides diagnostic studies including laboratory studies such as quantitative glomerular filtration rates, planar imaging, SPECT imaging, SPECT/CT imaging, and PET/CT imaging.
The Division of Nuclear Medicine is divided into four sections including General Nuclear Medicine, Nuclear Cardiology, PET/CT, and Radiopharmacy. Our Division is quite unique in having two cardiologists who oversee our Nuclear Cardiology Program. There is a close working relationship with the Division of Cardiology that includes a joint laboratory with the Division of Cardiology in an off-site clinic.
In addition to the full array of diagnostic nuclear medicine studies, we have a close interaction with the Division of General Surgery for providing sentinel lymph node studies. We provide the administration of the radiopharmaceuticals and imaging prior to surgery, and one of our technologists participates in the localization of the sentinel lymph nodes during surgery. We are active in radionuclide therapy including I-131 therapy for hyperthyroidism and thyroid cancer, Bexxar and Zevalin for lymphoma, and I-131 MIBG therapy for neuroendocrine tumors. The Division has an active research program in Nuclear Cardiology, PET, and SPECT. The Nuclear Cardiology Program has the largest database of nuclear cardiology studies in the U.S. We work closely with physicists in the Division for advances in PET/CT and SPECT/CT.